Stelexis is a Deerfield founded and solely funded New York-based cancer therapeutics company with a mission of transforming cancer therapeutics paradigm and patient care, through the discovery and development of novel drugs.

Biotechnology

Stelexis Therapeutics

Stelexis Therapeutics' headquarters in New York, NY, United States

Jiahao Chen

Lynn Biderman

Lumie Benard

Bozena Bugaj-Gaweda

Alice Tang

Jason Fuller

Uli Steidl

Evripids Gavathiotis

Roman Perez-Soler

Amit Verma

Mark Shtilerman

Derrick Rossi

Jonathan Ramos

This department oversees the strategic direction and overall management of the organization.

Executive Leadership

This department provides expert guidance and consultancy to support decision-making and strategic initiatives.

Advisory Services

The Research and Development team at Stelexis Therapeutics is focused on pioneering breakthrough cancer treatments. They leverage the Tumororigin™ platform and advanced drug discovery techniques to identify and develop novel therapeutic agents. This team plays a critical role in conducting cutting-edge research, managing lab operations, and translating scientific discoveries into viable cancer therapies aimed at improving patient outcomes.

Research and Development

This department focuses on bridging laboratory research with clinical applications to advance patient care.

Stelexis Therapeutics

Org chart

Board & advisors

Teams

Executive Leadership

Advisory Services

Research and Development

Translational Medicine

Offices

Stelexis Therapeutics

Org chart

Board & advisors

Teams

Executive Leadership

Advisory Services

Research and Development

Translational Medicine

Offices

Related companies